We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Legal requirements and good practice guidance for Veterinary Practice Premises Inspections.
Details of the VMD Corporate Priorities for 2026 - 2027.
List of currently authorised veterinary medicines containing controlled drugs (CDs) and their requirements for special storage and witnessed destruction.
Guidance for the veterinary pharmaceutical industry on the production of mock-ups for assessment.
Registers of authorised manufacturers, wholesale dealer sites and retailers.
How to obtain an authorisation to wholesale veterinary medicines.
Guidance for the pharmaceutical industry on how to apply to vary a veterinary Marketing Authorisation (MA) or Homeopathic Remedy.
How authorised veterinary medicines, products supplied under the cascade and products used under the Veterinary Medicines Internal Market Scheme and Veterinary Medicines Health Situation Scheme can be advertised.
Guidance for the veterinary pharmaceutical industry on applying for maximum residue limits (MRLs) in the UK.
Guidance on medicines for food and non-food horses and record keeping requirements including the horse passport.
List of words and phrases that will cause a veterinary product to be medicinal by presentation either through use or contextual use.
Summary of product characteristics for Syvazul BTV-3 vaccine in the UK
First published during the 2024 to 2026 Starmer Labour government
Urgent and clinically significant safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
How to report suspected illegal activity and how we will deal with these reports.
For manufacturers and distributors of intermediate and final feedingstuffs containing a medicinal premix or specified feed additives in Great Britain and Northern Ireland.
How a marketing authorisation holder should report a defect with a veterinary medicine.
How to comply with the exemption from the Veterinary Medicines Regulations that allow certain animal medicines to be sold without a marketing authorisation.
Guidance on the Batch Release Request scheme for an immunological veterinary medicine to be placed on the UK market.
Who in the pharmaceutical industry can be a Marketing Authorisation Holder, named distributor or local representative and how to make changes to these.
Explanation of what Pharmacovigilance means and who is responsible. These documents must be read with the Implementation Explainer at VMD Information Hub.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).